Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.

Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization of the ClinicalTrials.gov data ingest has been postponed from June 2025 to July 2025, and the revision number has been updated from v2.16.3 to v2.16.4.SummaryDifference0.6%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check41 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.15.1 to v2.16.0. Additionally, options to save and download have been added.SummaryDifference0.1%
- Check69 days agoChange DetectedThe page has undergone significant content removal, including the deletion of a detailed study description and inclusion/exclusion criteria for a clinical trial related to acute ischaemic stroke and transient ischaemic attack. A new revision number has been added, indicating an update to the document.SummaryDifference0.2%
Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.